That’s okay, “In Brilacidin oral rinse, we now have a Phase 3-ready drug candidate targeting an area of large unmet need—comprising a worldwide annual market opportunity estimated to approach $1 billion—for which currently there are no FDA-approved treatments.”
My guess is there’s a partner waiting to sign on to help develop this.
News 
Market Data 
Discover 
AI
